216 related articles for article (PubMed ID: 33254027)
1. Targeting metabolic plasticity in glioma stem cells in vitro and in vivo through specific inhibition of c-Src by TAT-Cx43
Pelaz SG; Jaraíz-Rodríguez M; Álvarez-Vázquez A; Talaverón R; García-Vicente L; Flores-Hernández R; Gómez de Cedrón M; Tabernero M; Ramírez de Molina A; Lillo C; Medina JM; Tabernero A
EBioMedicine; 2020 Dec; 62():103134. PubMed ID: 33254027
[TBL] [Abstract][Full Text] [Related]
2. Impairment of Autophagic Flux Participates in the Antitumor Effects of TAT-Cx43
Pelaz SG; Ollauri-Ibáñez C; Lillo C; Tabernero A
Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503072
[TBL] [Abstract][Full Text] [Related]
3. Connexin43 peptide, TAT-Cx43266-283, selectively targets glioma cells, impairs malignant growth, and enhances survival in mouse models in vivo.
Jaraíz-Rodríguez M; Talaverón R; García-Vicente L; Pelaz SG; Domínguez-Prieto M; Álvarez-Vázquez A; Flores-Hernández R; Sin WC; Bechberger J; Medina JM; Naus CC; Tabernero A
Neuro Oncol; 2020 Apr; 22(4):493-504. PubMed ID: 31883012
[TBL] [Abstract][Full Text] [Related]
4. A Short Region of Connexin43 Reduces Human Glioma Stem Cell Migration, Invasion, and Survival through Src, PTEN, and FAK.
Jaraíz-Rodríguez M; Tabernero MD; González-Tablas M; Otero A; Orfao A; Medina JM; Tabernero A
Stem Cell Reports; 2017 Aug; 9(2):451-463. PubMed ID: 28712848
[TBL] [Abstract][Full Text] [Related]
5. EGFR amplification and EGFRvIII predict and participate in TAT-Cx43266-283 antitumor response in preclinical glioblastoma models.
Álvarez-Vázquez A; San-Segundo L; Cerveró-García P; Flores-Hernández R; Ollauri-Ibáñez C; Segura-Collar B; Hubert CG; Morrison G; Pollard SM; Lathia JD; Sánchez-Gómez P; Tabernero A
Neuro Oncol; 2024 Mar; ():. PubMed ID: 38507464
[TBL] [Abstract][Full Text] [Related]
6. Connexin43 Region 266-283, via Src Inhibition, Reduces Neural Progenitor Cell Proliferation Promoted by EGF and FGF-2 and Increases Astrocytic Differentiation.
Talaverón R; Matarredona ER; Herrera A; Medina JM; Tabernero A
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238452
[TBL] [Abstract][Full Text] [Related]
7. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
8. A c-Src Inhibitor Peptide Based on Connexin43 Exerts Neuroprotective Effects through the Inhibition of Glial Hemichannel Activity.
Gangoso E; Talaverón R; Jaraíz-Rodríguez M; Domínguez-Prieto M; Ezan P; Koulakoff A; Medina JM; Giaume C; Tabernero A
Front Mol Neurosci; 2017; 10():418. PubMed ID: 29326548
[TBL] [Abstract][Full Text] [Related]
9. Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model.
Shibao S; Minami N; Koike N; Fukui N; Yoshida K; Saya H; Sampetrean O
Neuro Oncol; 2018 Feb; 20(3):343-354. PubMed ID: 29016888
[TBL] [Abstract][Full Text] [Related]
10. Targeting of glioma stem-like cells with a parthenolide derivative ACT001 through inhibition of AEBP1/PI3K/AKT signaling.
Hou Y; Sun B; Liu W; Yu B; Shi Q; Luo F; Bai Y; Feng H
Theranostics; 2021; 11(2):555-566. PubMed ID: 33391492
[TBL] [Abstract][Full Text] [Related]
11. Metabolic state of glioma stem cells and nontumorigenic cells.
Vlashi E; Lagadec C; Vergnes L; Matsutani T; Masui K; Poulou M; Popescu R; Della Donna L; Evers P; Dekmezian C; Reue K; Christofk H; Mischel PS; Pajonk F
Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16062-7. PubMed ID: 21900605
[TBL] [Abstract][Full Text] [Related]
12. Telomestatin impairs glioma stem cell survival and growth through the disruption of telomeric G-quadruplex and inhibition of the proto-oncogene, c-Myb.
Miyazaki T; Pan Y; Joshi K; Purohit D; Hu B; Demir H; Mazumder S; Okabe S; Yamori T; Viapiano M; Shin-ya K; Seimiya H; Nakano I
Clin Cancer Res; 2012 Mar; 18(5):1268-80. PubMed ID: 22230766
[TBL] [Abstract][Full Text] [Related]
13. VDAC2 interacts with PFKP to regulate glucose metabolism and phenotypic reprogramming of glioma stem cells.
Zhou K; Yao YL; He ZC; Chen C; Zhang XN; Yang KD; Liu YQ; Liu Q; Fu WJ; Chen YP; Niu Q; Ma QH; Zhou R; Yao XH; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
Cell Death Dis; 2018 Sep; 9(10):988. PubMed ID: 30250190
[TBL] [Abstract][Full Text] [Related]
14. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
15. Verteporfin inhibits oxidative phosphorylation and induces cell death specifically in glioma stem cells.
Kuramoto K; Yamamoto M; Suzuki S; Sanomachi T; Togashi K; Seino S; Kitanaka C; Okada M
FEBS J; 2020 May; 287(10):2023-2036. PubMed ID: 31868973
[TBL] [Abstract][Full Text] [Related]
16. A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.
Gangoso E; Thirant C; Chneiweiss H; Medina JM; Tabernero A
Cell Death Dis; 2014 Jan; 5(1):e1023. PubMed ID: 24457967
[TBL] [Abstract][Full Text] [Related]
17. Targeting Glioma Stem Cells by Functional Inhibition of Dynamin 2: A Novel Treatment Strategy for Glioblastoma.
Luwor R; Morokoff AP; Amiridis S; D'Abaco G; Paradiso L; Stylli SS; Nguyen HPT; Tarleton M; Young KA; O'Brien TJ; Robinson PJ; Chircop M; McCluskey A; Jones NC
Cancer Invest; 2019; 37(3):144-155. PubMed ID: 30907150
[TBL] [Abstract][Full Text] [Related]
18. Targeting Folate Metabolism Is Selectively Cytotoxic to Glioma Stem Cells and Effectively Cooperates with Differentiation Therapy to Eliminate Tumor-Initiating Cells in Glioma Xenografts.
Okada M; Suzuki S; Togashi K; Sugai A; Yamamoto M; Kitanaka C
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769063
[TBL] [Abstract][Full Text] [Related]
19. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
20. Repurposing phenformin for the targeting of glioma stem cells and the treatment of glioblastoma.
Jiang W; Finniss S; Cazacu S; Xiang C; Brodie Z; Mikkelsen T; Poisson L; Shackelford DB; Brodie C
Oncotarget; 2016 Aug; 7(35):56456-56470. PubMed ID: 27486821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
